Tamoxifen increases
muscular strength of the mdx dystrophic mice
Abstract from 44th Annual Meeting
- American Society for Cell Biology (December, 4-8, 2004, Washington)
Cavalsan,1 R. F. Vasquez,1 R. C. Lin,1
S. B. Zyngier,1 F. J. Velloso,2 B. H. Santos,2
L. L. Fogaca,2 M. Vainzof,2 D. Feder1 ;
1 Pharmacology, ABC Faculty of Medicine, Santo Andre, Brazil, 2
Human Genome Research Center - IB USP, Sao Paulo, Brazil
The mdx
mice is a well-known model of Xp21 dystrophin-deficient muscular dystrophy.
Although a good genetic and biochemical model, the mdx shows no muscle
weakness, but under physical exercise, a loss of muscular strength can be
detected. Here we have tested the possible therapeutic beneficial effect of
Tamoxifen in the degenerative process of the dystrophic muscle, analyzing
muscle strength of tamoxifen treated mdx mice, under intensive physical
exercise. A total of 22 mices aged 4 weeks were divided into 3 groups: control
(n= 8) treated with 0.5 mL saline ip, Tamoxifen 5 mg/Kg body weight ip (n= 8)
daily and Tamoxifen 10 mg/Kg ip (n=6) daily. The exercise protocol was done in
a wheel revolving at 18 cm/s, for 10 minutes, twice a day, 5 days/week, up to
12 weeks. Whole-body strength was measured weekly using a force transducer
coupled to a computer. Mice tails were attached via a non-flexibile nylon cord
to the transducer, the animals were electricly stimulated to run, and the force
to pull the cord was registered continuously. Results were analyzed by the
Kruskal-Wallis test. The mice treated either with 5 mg/Kg (6.26+ 1.44 dynes/g
body weight) or 10 mg/Kg (6.46+ 2.52) showed a significant increase of
muscular strength (p<0.05) compared to the control group (3.66+ 0.77)
starting in the 5th week, and maintaining significance up to the end
of the experiment. Histological and histochemical analysis of the complex of
the gastrocnemius muscle are under analysis, but preliminary results suggest a
less degree of degeneration in the Tamoxifen treated groups.
Tamoxifen
is an anti tumoral drug and act on TGF-beta. Its possible therapeutic effect in
the degenerative process of the dystrophic muscle could ameliorates the
clinical course of dystrophic patients. FAPESP-CEPID, CNPq, PRONEX,
NEPAS-FMABC.
Human Retinal
Dystrophin Transgene Converts Lethal Muscular Dystrophy into Viable Mild Myopathy
in Dystrophin-Utrophin Null Mice
Abstracts from 44th Annual Meeting
- American Society for Cell Biology (December, 4-8, 2004, Washington)
R. Gaedigk,1,2 D. J. Law,3 K.
M. Fitzgerald-Gustafson,4,2 S. G. McNulty,1 N. N. Nsumu,1
A. C. Modrcin,5 R. J. Rinaldi,5 D. Pinson,6 S.
C. Fowler,7 M. Bilgen,4,8 J. Burns,9 S. D.
Hauschka,10 R. A. White1,2 ; 1 Medical
Research, Children's Mercy Hospitals & Clinics, Kansas City, MO, 2
Pediatrics, UMKC School of Medicine, Kansas City, MO, 3 School of
Biological Sciences, Univ. of Missouri-Kansas City, Kansas City, MO, 4
Hoglund Brain Imaging Center, Univ. of Kansas Medical Center, Kansas City, KS, 5
Rehabilitation Medicine, Children's Mercy Hospitals & Clinics, Kansas City,
MO, 6 Pathology & Laboratory Medicine, Univ. of Kansas Medical
Center, Kansas City, KS, 7 Pharmacology & Toxicology, Univ. of
Kansas, Lawrence, KS, 8 Molecular & Integrative Physiology,
Univ. of Kansas Medical Center, Kansas City, KS, 9 Veterinary
Imaging Services, Topeka, KS, 10 Biochemistry, Univ. of Washington,
Seattle, WA
Duchenne muscular dystrophy
(DMD) is a progressive muscle disease caused by severe dystrophin gene
mutations that often result in death by the third decade. The mdx mouse
is the most commonly used DMD model. Although they lack dystrophin and have
underlying muscle disease, mdx mice appear physically normal. This may
be partially due to compensatory expression of the dystrophin-related protein,
utrophin. In contrast, double mutant mice (DM), deficient for both dystrophin
and utrophin (mdx/+, utrn -/-), die by 3 months of age and suffer
from severe muscle weakness, pronounced growth retardation, kyphosis, weight
loss, slack posture, and immobility (Deconinck et al. (1997) Cell 90: 717-727;
Grady et al. (1997) Cell 90: 729-738). These features make them an excellent
physiological model for DMD research. The capacity of a naturally occurring
isoform, human retinal dystrophin (Dp260), to compensate for the missing muscle
isoform Dp427 was tested in DM mice. The expression of this transgene prevents
premature death and reduces the severe muscular dystrophy phenotype to a mild
myopathy. Electromyography (EMG), histology, radiography, magnetic resonance
imaging, and behavior studies show that DM transgenic mice grow normally, have
normal spinal curvature and locomotion, and have reduced muscle pathology. EMG
and histologic data from transgenic DM mice are typical of mild myopathy, while
the DM mice exhibit severe abnormalities commonly seen in human
dystrophinopathies. The expression of human Dp260 in DM mice converts a severe
and lethal muscular dystrophy into a non-lethal mild myopathy. Muscle-specific
expression of Dp260 could have several advantages over other treatments of DMD
Visualization of Ectopic
Calcification in mdx Mouse Skeletal Muscle
N. Kikkawa, T. Ohno, M. Shiozuka, R. Matsuda; The Graduate School of
Arts and Sciences, The University of Tokyo, Tokyo, Japan
It
has been demonstrated that osteogenic differentiation of skeletal muscle cells
are induced by osteogenic factors, such as bone morphogenetic proteins, both in
vitro and in vivo. Spontaneous ectopic bone formation in vivo has also been
reported in, for instance, fibrodysplasia ossificans progressiva, which
is a rare bone disorder. Another example of self-generating ectopic
calcification has been found in skeletal muscle of mdx mouse, a model of
Duchenne muscular dystrophy (DMD).
We observed the ectopic calcification in mdx mouse
thigh muscle by using x-ray micro CT-scanner SkyScan-1074, which gives resolution
of 22um. The x-ray images were reconstructed into three dimentional visions.
Calcifications were found as spicular structures running parallel to the muscle
fiber. Paraffin sections of the regions found by X-ray microtomography were Von
Kossa stained to confirm calcium deposits. We also detected ectopic
calcifications of living mice with mouse-whole-body x-ray CT-scanner of Aloka.
No ectopic calcification was observed in skeletal muscle of B10 mouse, which
possesses normal dystrophin gene and was used as a negative control.
Calcified regions of mdx mouse thigh did not overlap with the Evans
blue-positive areas but corresponded to some of the regenerating areas. Thus,
ectopic calcification can be a diagnostic marker of muscle regeneration in mdx
mice, and be available to determine the effects of drug or gene therapies.
Muscle Proteoglycan Levels in Duchenne Muscular
Dystrophy Differ from Other Muscular Dystrophies
S. Zanotti,
E. Canioni, F. Cornelio, L. Morandi, M. Mora; Neuromuscular Diseases and
Neuroimmunology, National Neurological Institute C. Besta, Milano, Italy
Biglycan
and decorin are small leucine-rich extracellular proteoglycans that interact
with several matrix proteins particularly collagens, and also with cytokines
whose activity they may modulate. To better understand the role of these
proteoglycans in muscle fibrosis in muscular dystrophies, we investigated the
expression of their transcripts and proteins in several forms of muscular
dystrophy compared to age-matched controls. mRNAs of both proteoglycans were
significantly downregulated in Duchenne muscular dystrophy and significantly
upregulated in Becker muscular dystrophy, sarcoglycanopathies and
dysferlinopathy. By immunohistochemistry, decorin and biglycan were mainly
localized in connective tissue and apparently increased with age. Their
presence increased in relation to increased fibrosis in all types of dystrophic
muscle.
The increase in biglycan and
decorin in most muscle diseases indicates a role of these proteoglycans in the
extracellular matrix organization. The significant decrease of decorin and
biglycan mRNA in DMD distinguishes this disease from the other studied and may
be related to the high levels of TGF-beta1 and TNF-alpha found in this disease.
Sex Differences in Muscle Stem
Cell Transplantation Efficiency
B. Deasy,1
A. Lu,1 K. Urish,1 J. Tebbets,1 B. Gharaibeh,1
R. Rubin,2 J. Huard1 ; 1 University of
Pittsburgh, Pittsburgh, PA, 2 Allegheny General Hospital,
Pittsburgh, PA
We previously demonstrated that muscle-derived stem cells (MDSCs) efficiently regenerate skeletal muscle tissue after transplantation into dystrophic mdx mice, which model muscular dystrophy. Here we show that transplantation of female MDSC (F-MDSC) rather than male MDSCs (M-MDSC) significantly improves skeletal muscle regeneration.
We transplanted F-MDSCs into the gastrocnemius muscles of female mdx mice and the same number of M-MDSCs into the gastrocnemius muscles of male mdx mice. We used a previously described protocol to measure the cells’ regeneration index (RI)_the number of dystrophin-positive fibers in the host muscle per 105 donor cells_two weeks after transplantation. The F-MDSCs elicited significantly superior muscle regeneration equivalent to a 6-fold increase in efficiency (F-MDSC RI=686±120 versus M-MDSCs RI=105±25, P< 0.01). Sex-crossed transplantation also demonstrated the same trend for the donor cells. We hypothesize that this difference may be related to reduced ability of the M-MDSC to self-renew or to tolerate hypoxic stress. F-MDSCs maintained CD34 expression (>80% of total cells) for up to 200 population doublings, whereas M-MDSCs exhibited a rapid drop in CD34 expression (from >80% to <30% of total cells) after only 45 population doublings. To support the notion that the F-MDSC are more tolerant to stress, we also found that proliferation of F-MDSC was less affected by low O2 conditions as compared with M-MDSC.
Our discovery of sex-related differences in muscle stem cell biology reveals clear limitations to using male stem and progenitor cells for cell-tracking purposes. This finding also warrants careful consideration by researchers working to identify optimal populations of stem and progenitor cells for use in cell therapy and tissue engineering, clinicians who perform bone marrow stem cell transplantation, and basic scientists investigating cell and developmental biology.